CB 65

CAS No. 913534-05-1

CB 65( —— )

Catalog No. M35264 CAS No. 913534-05-1

CB 65 is a high affinity and selective CB2 receptor agonist with Ki values of 3.3 and > 1000 nM for CB2 and CB1 receptors respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 88 Get Quote
5MG 132 Get Quote
10MG 198 Get Quote
25MG 325 Get Quote
50MG 483 Get Quote
100MG 672 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CB 65
  • Note
    Research use only, not for human use.
  • Brief Description
    CB 65 is a high affinity and selective CB2 receptor agonist with Ki values of 3.3 and > 1000 nM for CB2 and CB1 receptors respectively.
  • Description
    CB65 is a potent and high affinity CB2 selective agonist with a Ki value of 3.3 nM. CB65 exhibits a Ki of >1000 nM for CB1 receptor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Cannabinoid Receptor
  • Recptor
    Cannabinoid Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    913534-05-1
  • Formula Weight
    417.93
  • Molecular Formula
    C22H28ClN3O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 5 mg/mL (11.96 mM; Ultrasonic (<60°C)
  • SMILES
    C(CN1CCOCC1)N2C=3C(C(=O)C(C(NC4CCCCC4)=O)=C2)=CC=C(Cl)C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. CB 65 is a high affinity and selective CB2 receptor agonist; Ki?values are 3.3 and > 1000 nM for CB2 and CB1 receptors respectively. ?
molnova catalog
related products
  • CB2R PAM

    CB2R PAM is an orally active cannabinoid type 2 receptor (CB2Rs) positive allosteric modulator that enhances CP 55940 and 2-Arachidonylglycerol-stimulated [35S]GTPγS binding to CB2 receptors without affecting receptor activity in the absence of agonists.

  • SR 144528

    A highly potent, selective and orally active antagonist of CB2 receptor with Ki of 0.6 nM.

  • SMM-295

    A novel potent, selective cannabinoid receptor 2 (CB2) agonist with Ki of 12 nM.